메뉴 건너뛰기
Journal of Gastroenterology and Hepatology (Australia)
Volumn 26, Issue 2, 2011, Pages 215-217
Solid pseudopapillary tumor and wnt signaling pathway...Way to go!?
Author keywords

[No Author keywords available]
Indexed keywords

CELECOXIB; CETUXIMAB; ERLOTINIB; GEFITINIB; IMATINIB; PERIFOSINE; SELUMETINIB; TEMSIROLIMUS; UVOMORULIN; WNT PROTEIN; XL 147;
EID: 78851468850     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06570.x     Document Type: Editorial
Times cited : (3)
References (10)
  • 1
    • 78851470140 scopus 로고    scopus 로고
    • Clinical and immunohistochemical features of 34 solid pseudopapillary tumors of the pancreas
    • Nguyen N, Johns A, Gill A etal. Clinical and immunohistochemical features of 34 solid pseudopapillary tumors of the pancreas. J. Gastroenterol. Hepatol. 2011; 26: 267-74.
    • (2011) J. Gastroenterol. Hepatol. , vol.26 , pp. 267-274
    • Nguyen, N.1    Johns, A.2    Gill, A.3
  • 2
    • 34247214944 scopus 로고    scopus 로고
    • Solid-papillary tumors of the pancreas: histopathology
    • Santini D, Poli F, Lega S. Solid-papillary tumors of the pancreas: histopathology. JOP 2006; 7: 131-6.
    • (2006) JOP , vol.7 , pp. 131-136
    • Santini, D.1    Poli, F.2    Lega, S.3
  • 3
    • 0002565615 scopus 로고
    • Atlas of Tumor Pathology
    • Washington, DC: Armed Forces Institute of Pathology
    • Frantz VK. Tumors of the pancreas. In: Atlas of Tumor Pathology, Vol. 7. Washington, DC: Armed Forces Institute of Pathology, 1959; 32-3.
    • (1959) Tumors of the pancreas , vol.7 , pp. 32-33
    • Frantz, V.K.1
  • 4
    • 56049121938 scopus 로고    scopus 로고
    • Revision 2: an immunohistochemical approach and evaluation of solid pseudopapillary tumor of the pancreas
    • Serra S, Chetty R. Revision 2: an immunohistochemical approach and evaluation of solid pseudopapillary tumor of the pancreas. J. Clin. Pathol. 2008; 61: 1153-59.
    • (2008) J. Clin. Pathol. , vol.61 , pp. 1153-1159
    • Serra, S.1    Chetty, R.2
  • 5
    • 0036105502 scopus 로고    scopus 로고
    • Solid pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations
    • Abraham SC, Klimstra DS, Wilentz RE etal. Solid pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am. J. Pathol. 2002; 160: 1361-69.
    • (2002) Am. J. Pathol. , vol.160 , pp. 1361-1369
    • Abraham, S.C.1    Klimstra, D.S.2    Wilentz, R.E.3
  • 6
    • 0035577867 scopus 로고    scopus 로고
    • Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm
    • Tanaka Y, Kato K, Notohara K etal. Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res. 2001; 61: 8401-04.
    • (2001) Cancer Res. , vol.61 , pp. 8401-8404
    • Tanaka, Y.1    Kato, K.2    Notohara, K.3
  • 7
    • 34247361281 scopus 로고    scopus 로고
    • Loss of cell-adhesion molecule complexes in solid pseudopapillary tumor of pancreas
    • Tang WT, Stelter AA, French S etal. Loss of cell-adhesion molecule complexes in solid pseudopapillary tumor of pancreas. Mod. Pathol. 2007; 20: 509-13.
    • (2007) Mod. Pathol. , vol.20 , pp. 509-513
    • Tang, W.T.1    Stelter, A.A.2    French, S.3
  • 8
    • 76349103270 scopus 로고    scopus 로고
    • Virtual prototyping study shows increased ATPase activity of Hsp90 to be the key determinant of cancer phenotype
    • Vali S, Pallavi R, Kapoor S, Tatu U. Virtual prototyping study shows increased ATPase activity of Hsp90 to be the key determinant of cancer phenotype. Syst. Synth. Biol. 2010; 4: 25-33.
    • (2010) Syst. Synth. Biol. , vol.4 , pp. 25-33
    • Vali, S.1    Pallavi, R.2    Kapoor, S.3    Tatu, U.4
  • 9
    • 77649184903 scopus 로고    scopus 로고
    • Celecoxib inhibits MDR1 expression through COX-2 dependent mechanism in human hepatocellular carcinoma (HepG2) cell line
    • Roy KR, Reddy GV, Maitreyi L etal. Celecoxib inhibits MDR1 expression through COX-2 dependent mechanism in human hepatocellular carcinoma (HepG2) cell line. Cancer Chemother. Pharmacol. 2010; 65: 903-11.
    • (2010) Cancer Chemother. Pharmacol. , vol.65 , pp. 903-911
    • Roy, K.R.1    Reddy, G.V.2    Maitreyi, L.3
  • 10
    • 64749113970 scopus 로고    scopus 로고
    • Drugging the wnt pathway: problems and progress
    • Garber K. Drugging the wnt pathway: problems and progress. J. Natl. Cancer Inst. 2009; 101: 548-50.
    • (2009) J. Natl. Cancer Inst. , vol.101 , pp. 548-550
    • Garber, K.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.